Breast cancer |
TAM/M2 |
IL‐6R |
MCT‐1 |
Reprograms EMT and macrophages as well as inhibits tumor progression |
12
|
CD4+ T cell |
CAPN6 |
/ |
Regulates cellular activities associated with CD4+ T cell infiltration |
20
|
Gastric cancer |
T, B, and NK cells |
PD‐L1 |
/ |
Suppresses the proliferation as well as the migration and invasion of tumor |
23
|
Lung cancer |
TAM |
KLF4 |
/ |
Modulation of macrophage polarization reverses the processes of tumorigenesis |
15
|
macrophages and Treg cells |
PD‐L1 |
p53 |
Regulates tumor immune evasion |
24
|
Glioma |
MSCs |
SIRT1 |
p53, Cdkn1a, and Cdkn2c |
Induces glioma cell senescence |
25
|
Liver cancer |
Treg cells |
CCL22 |
/ |
Promotes tumor cells to escape from immune surveillance |
26
|
Head and neck squamous cell carcinoma |
pro‐B cells, CD8 naïve T cells, Th1 cells |
PD‐L1 |
MET |
Suppresses oncogenic MET and restores tumor immunity |
13
|